To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107

NCT06816719 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Treatment A: JW0106 1 tablet + C2101 1 tablet
DRUG: Treatment B: JW0107 1 tablet

Sponsor

JW Pharmaceutical